The lack of a satisfactory method for the determination of the aureomycin concentration of the blood has been noted by various investigators (Collins et al., 1948 a,b; Ross et al., 1948; Finland et al., 1948) . The factor chiefly responsible for this difficulty is the instability of aureomycin at the temperature at which the analysis has been performed, 37 C. In addition, it has been shown by Paine et al. (1948) incubating the tubes overnight at room temperature instead of at 37 C. Good growth and clear-cut end points resulted, also a satisfactory degree of accuracy. A detailed description of the method of assay, the results of assays of samples containing known concentrations of aureomycin in normal human serum, and finally the blood levels determined after oral administration of 250 and 500 mg, respectively, to two groups of patients form the basis for the present report.
The lack of a satisfactory method for the determination of the aureomycin concentration of the blood has been noted by various investigators (Collins et al., 1948 a,b; Ross et al., 1948; Finland et al., 1948) . The factor chiefly responsible for this difficulty is the instability of aureomycin at the temperature at which the analysis has been performed, 37 C. In addition, it has been shown by Paine et al. (1948) that deterioration is even greater at this temperature when the antibiotic is kept in low concentration in broth, serum, or 10 per cent horse blood agar. To overcome this handicap in the method described by Dornbush and Pelcak (1948) the tubes are incubated for 4 hours only at 37 C since longer incubation has been found to result in considerable deterioration of the drug. Price et al. (1948) A tube dilution method using 2-ml amounts is employed. Fresh meat extract broth, pH 7.0 to 7.2, is the medium and diluent. The Bacillus 5 suspension is prepared by inoculating 10 ml of broth from a stock plain agar slant culture maintained at 4 to 6 C. After incubation for 6 hours at 37 C, the culture is adjusted to an optical density of 0.05 on the "lumetron" photoelectric colorimeter using a red filter, and then further diluted 1:100,000. One ml of this suspension, The serum concentration is calculated by dividing the amount of aureomycin that inhibits completely the growth of the Bacillu 5 suspension by the amount of serum required to inhibit the standard inoculum. If no inhibition takes place in the serum series or if a level greater than 0.4 jg per ml is anticipated, the serum is diluted 1:10 or higher and the calculated result is multiplied by the dilution factor. The smallest concentration measurable by this procedure is 0.04 pg per ml.
EXPERIMENTAL RESULTS
In order to test the accuracy of this method, 36 trial samples containing known concentrations of aureomycin dissolved in normal human serum were prepared and assayed promptly. The results are imustrated in figure 1 in which the concentration of each sample is plotted against the level found. The solid line represents perfect correlation between actual and estimated results. As may be noted from the graph, good correlation was found between both values. It may also be seen that the discrepancies that appeared were on both sides of the line. Had deterioration of the antibiotic occurred, all variations should have been below the line. 
14]DETERBMINATION OF AURbOMYCIN IN BLOOD
Aureomycin blood levels as determined by the method described were investigated in two groups of patients. One group received orally a single dose of 250 mg and the other 500 mg. Blood specimens were obtained, under sterile conditions, from the antecubital vein periodically up to 24 hours after administration. After clotting, the serum was separated off by centrifugation and the aureomycin concentration of each sample was determined.
As may be noted from table 2, peak levels were found 2 to 6 hours after oral administration. The antibiotic was still detectable in all patients receiving Prepored uourec n ccncentvations in seum (pg/mi) 
